Lysophosphatidic acid LPA1 and LPA3 receptors play roles in the maintenance of late tissue plasminogen activator-induced central poststroke pain in mice
DOI: 10.1016/j.ynpai.2018.07.001
Keywords: CPSP , central post-stroke pain , NeuP , neuropathic pain , MCA , middle cerebral artery , PIT , photochemically induced thrombosis , tPA , tissue-type plasminogen activator , LPA1 , lysophosphatidic acid receptor 1 , LPA3 , lysophosphatidic acid receptor 3 , LC–MS/MS , liquid chromatography–mass spectrometry , MD , medial dorsal thalamus , LPA1-KO , LPA1-deficient , pSNL , partial sciatic nerve ligation , RB , Rose Bengal , i.v. , intravenously , TTC , 2 ,3 ,5-triphenyltetrazolium chloride , PFA , paraformaldehyde , HE , Hematoxylin and Eosin , EPW , electrical stimulation-induced paw withdrawal , PWL , paw withdrawal latency , DMSO , dimethyl sulfoxide , MRM , multiple reaction monitoring , S-I , sensory cortex , tMCAO , transient middle cerebral artery occlusion Central poststroke pain , Lysophosphatidic acid , LC–MS/MS , Photochemically induced thrombosis , tPA
Abstract:
Full-Text